We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

No cure, more pain

17 May 2004 By Robert Cyran

The French chemicals group has fought off insolvency with a successful rights and bond issue. But the treatment did not cure, and has given rise to a nasty set of side effects.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)